VANITA ROBINSON: Open Payments
NPI 1861806101 · PLYMOUTH, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,879 in 111 payments from 11 companies in 2025. Trend: 2023 $1,727 · 2024 $1,634 · 2025 $1,879
Food & beverage: $1,701Education: $178
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 23 | $444 |
| Teva Pharmaceuticals USA, Inc. | 20 | $377 |
| E.R. Squibb & Sons, L.L.C. | 28 | $357 |
| Otsuka America Pharmaceutical, Inc. | 14 | $271 |
| ABBVIE INC. | 9 | $150 |
| Axsome Therapeutics, Inc. | 9 | $143 |
| Vanda Pharmaceuticals Inc. | 2 | $37 |
| Noven Therapeutics, LLC | 2 | $34 |
| Luye Pharma (USA) Ltd. | 2 | $34 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17 |
Products named: ARISTADA, COBENFY, VRAYLAR, Auvelity, UZEDY, ABILIFY MAINTENA, ABILIFY ASIMTUFII, REXULTI.
Industry payments across MI — which companies pay providers there.
